Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study-Reference-Cited by-同舟云学术

Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study

Published:2016-04-15 Issue:12 Volume:31 Page:2073-2085
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrol. Dial. Transplant.

Author:

Galle Jan-Christoph,Addison Janet,Suranyi Michael G.,Claes Kathleen,Di Giulio Salvatore,Guerin Alain,Herlitz Hans,Kiss István,Farouk Mourad,Manamley Nick,Wirnsberger Gerhard,Winearls Christopher

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/31/12/2073/17109369/gfw047.pdf

Reference30 articles.

1. Prevalence of Anemia in Chronic Kidney Disease in the United States

2. Optimizing the use of erythropoietic agents—pharmacokinetic and pharmacodynamic considerations;Macdougall;Nephrol Dial Transplant,2002

3. Cody J , Daly C , Campbell M et al . Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev 2005: CD003266

4. Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease

5. Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anemia in Chronic Kidney Disease and After Kidney Allotransplantation (Systematic Review);Current Topics in Anemia;2018-02-07

2. Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients;Current Pharmaceutical Biotechnology;2017-05-05